Jianfeng Group Pro 2015-024 (Announcement on Resolutions of the 4th Session of the 8th Board of Supervisors)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2015-024
Bond Abbreviations: 13 Peak 01 Bond Code: 122227
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Supervisors
The Board of Supervisors and all supervisors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Meeting of the 1. Board of Supervisors
(I) The convening and convening of this meeting of the Board of Supervisors complies with relevant laws, regulations and the relevant provisions of the Company's Articles of Association.
(II) 2015# On August 14, 36, the company issued the notice of the meeting of the board of supervisors by fax, e-mail and personal delivery.
(III) 2015# On August 26, 40, the board of supervisors meeting was held in the conference room on the third floor of Jianfeng Building, Jinhua City, Zhejiang Province by on-site voting.
(IV) 4supervisors who should attend the meeting of the board of supervisors, 4 supervisors who actually attended the meeting, and 4 valid votes for the meeting.
(V) This board of supervisors is presided over by Mr. Li Ziqiang, chairman of the board of supervisors.Review of 2. Board of Supervisors Meeting
1
, Company 2015 Semi-annual Report
The Board of Supervisors confirmed that the information contained in the Company 2015Semi-annual Report does not contain any false records, misleading statements or major omissions, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
After deliberation and voting, the bill was passed by 4votes in favor, 0 votes against, and 0 abstentions.
2, Proposal on Adding Supervisors
As the former supervisor of the company, Mr. Ouyang Shaojian, resigned as a supervisor of the company, the company needs to add a supervisor. The company's largest shareholder, Jinhua Tongji State-owned Assets Investment Company, recommended Mr. Wang Jian (resume attached) as a candidate for the company's supervisor and submitted it to the company to 2015 the election of the first extraordinary general meeting of shareholders in.
After deliberation and voting, the bill was passed by 4votes in favor, 0 votes against, and 0 abstentions.
hereby announcesZhejiang Jianfeng Group Co., Ltd.
Board of Supervisors
August 28, 2015Attached: Resume of Supervisor Candidate
Mr. Wang Jian, 1976# born in May 96, bachelor degree, economist. He joined the work in August 1994 and successively worked in Jinhua Railway, Jinhua Property Exchange, Jinhua Asset Management Co., Ltd. and other units. Since January 2015, he has worked in Jinhua Tongji State-owned Assets Investment Co., Ltd. He is currently the deputy general manager of Jinhua Tongji State-owned Assets Investment Co., Ltd.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31